Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma

Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma

The aim of our study was to explore the relationship between the methylation status of the alpha-1A adrenergic receptor (ADRA1A) gene and hepatocellular carcinoma (HCC). We combined our in-house data-set with the Cancer Genome Atlas (TCGA) data-set to screen and identify the methylation status and e...

Full description

Bibliographic Details
Main Authors: Guoqiao Chen, Xiaoxiao Fan, Yirun Li, Lifeng He, Shanjuan Wang, Yili Dai, Cui Bin, Daizhan Zhou, Hui Lin
Format: Article
Language:English
Published: Taylor & Francis Group 2020-07-01
Series:Epigenetics
Subjects:
hcc
methylation
adra1a
clinicopathological characteristics
biomarker
Online Access:http://dx.doi.org/10.1080/15592294.2019.1709267

Internet

http://dx.doi.org/10.1080/15592294.2019.1709267

Similar Items